ReviewMolecular genetics and genomics : MGG2025
Role of Php domain and related enzymes in the enzymatic degradation of G-series nerve agents.
Review in Molecular genetics and genomics : MGG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The enzymatic breakdown of organophosphate (OP) nerve agents marks a pivotal advancement in both bioremediation and biodefense. This review explores the genetic diversity and evolutionary lineage of phosphotriesterase-related proteins across multiple species, with a particular focus on the Php domain, key to substrate recognition and hydrolysis. The study underscores the functional importance of Php-containing enzymes in neutralizing G-series nerve agents, highlighting their promise for environmental detoxification and defense applications. By laying the groundwork for enzyme-based OP degradation strategies, this work emphasizes the need for continued research and optimization of these enzymes and their microbial hosts to support sustainable remediation efforts.
Indexed as
Identifiers
40839030What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.